Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA let-7a is a highly conserved, small non-coding RNA molecule that serves as a master regulator of gene expression by binding to the 3' untranslated regions (UTRs) of target messenger RNAs (Reinhart et al., Nature, 2000). As a founding member of the let-7 family, it is primarily recognized for its role as a potent tumor suppressor, where it negatively regulates several key oncogenes including RAS, MYC, and HMGA2 (Johnson et al., Cell, 2005; Sampson et al., Cancer Res, 2007). In various malignancies, such as lung and breast cancer, let-7a expression is frequently lost or significantly reduced, contributing to uncontrolled cell proliferation and metastasis (Takamizawa et al., Cancer Res, 2004). Beyond its role in oncology, let-7a is essential for proper developmental timing, stem cell differentiation, and the regulation of glucose metabolism (Boyerinas et al., Cancer Res, 2010). Therapeutic approaches currently under investigation involve the use of synthetic let-7a mimics to restore its function in cancer cells and inhibit tumor growth (Trang et al., Mol Ther, 2011). However, challenges remain regarding the efficient delivery of these RNA-based therapeutics and the potential for off-target effects or innate immune system activation (Ling et al., Nat Rev Drug Discov, 2013).
Post-transcriptional gene silencing via seed-sequence-mediated binding to the 3' UTR of target mRNAs, leading to translational repression or mRNA cleavage (Bartel, Cell, 2004).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA let-7a (let-7a) (let-7a).